United States · FDA National Drug Code directory
Histanaz
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 29978-129_5013a487-2901-ef02-e063-6394a90a2902
- Product NDC
- 29978-129
- Form
- TABLET
- Composition / generic term
- Pseudoephedrine HCL, Pyrilamine Maleate
- Labeler
- Capital Pharmaceutical, LLC
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20250908
- Source listing expiry
- 20271231
Source-listed ingredients
- PSEUDOEPHEDRINE HYDROCHLORIDE — 60 mg/1
- PYRILAMINE MALEATE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (29978-129-10) · 29978-129-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →